Teligent Lender Slams Creditor Group Bid To Claw Back Cash
A lender for bankrupt generic pharmaceutical company Teligent Inc. slammed a bid by unsecured creditors for derivative standing to claw back a $10 million reserve fund, insisting the debtor didn't incur...To view the full article, register now.
Already a subscriber? Click here to view full article